An official website of the United States government
NIH Guide: Weekly Index for September 20, 2024
Weekly NIH Guide Notices
September 20, 2024
General Notices
-
Notice of Participation of the National Cancer Institute (NCI) in RFA-NS-24-041, "NIH HEAL Initiative: Coordinated Approaches to Pain Care in Health Care Systems (UG3/UH3 - Clinical Trial Optional).
(NOT-CA-24-108)National Cancer Institute
-
Notice of Question and Answer "Office Hours" with NIH Staff for the Translating Socioenvironmental Influences on Neurocognitive Development and Addiction Risk (TranSINDA) Funding Opportunities RFA-DA-25-037, RFA-DA-25-038
(NOT-DA-24-042)National Institute on Drug Abuse
-
Notice of NIH Participation in the National Science Foundation Solicitation NSF 24-603: Biomedical Research Initiative for Next-Gen BioTechnologies - SynBio Control (BRING SynBio)
(NOT-EB-24-012)National Institute of Biomedical Imaging and Bioengineering
-
NICHD Notice of Availability of Frequently Asked Questions (FAQs) for The Road to Prevention of Stillbirth: RFA-HD-25-010 (UG1) and RFA-HD-25-011 (UM2)
(NOT-HD-24-032)Eunice Kennedy Shriver National Institute of Child Health and Human Development
-
Notice of Pre-Application Technical Assistance Webinar for RFA-HS-24-004 for State-based Healthcare Extension Cooperatives to Accelerate Implementation of Actionable Knowledge into Practice (U19)
(NOT-HS-24-025)Agency for Healthcare Research and Quality
-
Notice of Early Expiration of the Tobacco Regulatory Science K Notice of Funding Opportunity Announcements (NOFOs): RFA-OD-22-023, RFA-OD-22-024, RFA-OD-22-025, and RFA-OD-22-026
(NOT-OD-24-172)Office of Disease Prevention
-
Findings of Research Misconduct
(NOT-OD-24-173)Office of the Director, NIH
-
Findings of Research Misconduct
(NOT-OD-24-174)Office of the Director, NIH
Notice of Changes to Funding Opportunities
-
Notice of Participation of the NIAAA in NOSI: Analysis of Existing Linked Datasets to Understand the Relationship between Housing Program Participation and Risk for Chronic Diseases and Other Conditions (R01-Clinical Trial Not Allowed).
(NOT-AA-24-009)National Institute on Alcohol Abuse and Alcoholism
-
Notice of Participation of the NIAAA in RFA-HD-25-003 "Pediatric HIV/AIDS Cohort Study (PHACS) (U19 Clinical Trial Not Allowed)"
(NOT-AA-24-010)National Institute on Alcohol Abuse and Alcoholism
-
Notice of Change: NINDS Participation in PAR-24-131/PAR-24-133 "Small Business Transition Grant for New Entrepreneurs" (R43/R44 Clinical Trial Not Allowed)/(R41/R42 Clinical Trial Not Allowed)
(NOT-NS-24-134)National Institute of Neurological Disorders and Stroke
Notices of Special Interest
-
Notice of Special Interest (NOSI): Training Program in Application of Artificial Intelligence in Development of Treatment for Substance Use Disorders
(NOT-DA-26-004)National Institute on Drug Abuse
-
Notice of Special Interest (NOSI): NIDDK T32 Medical Student Research Training Administrative Supplement
(NOT-DK-24-037)National Institute of Diabetes and Digestive and Kidney Diseases
-
Notice of Special Interest (NOSI): Quantum Sensing in Biomedical Applications (SBIR/STTR)
(NOT-EY-24-014)National Eye InstituteNational Cancer InstituteNational Heart, Lung, and Blood InstituteNational Center for Advancing Translational SciencesNational Institute of Biomedical Imaging and BioengineeringNational Center for Advancing Translational Sciences
Funding Opportunities
-
Imaging - Science Track Award for Research Transition (I/START) (R03 Clinical Trial Optional)
(PAR-24-297)National Institute on Drug AbuseApplication Receipt Date(s): January 7, 2028
-
Mechanism for Time-Sensitive Substance Use Research (R21 Clinical Trial Optional)
(PAR-24-298)National Institute on Drug AbuseApplication Receipt Date(s): September 9, 2027
-
U.S.-South Africa Program for Collaborative Biomedical Research Phase 3 (HIV/AIDS) (R01 Clinical Trial Optional)
(RFA-AI-24-023)National Institute of Allergy and Infectious DiseasesNational Institute on Alcohol Abuse and AlcoholismNational Cancer InstituteEunice Kennedy Shriver National Institute of Child Health and Human DevelopmentNational Institute of Mental HealthOffice of AIDS ResearchApplication Receipt Date(s): March 12, 2025
-
Cellular Models of HIV Pathogenesis within NIDDK Mission Areas (R01 Clinical Trial Not Allowed)
(RFA-DK-25-021)National Institute of Diabetes and Digestive and Kidney DiseasesOffice of Research on Women's HealthApplication Receipt Date(s): March 20, 2025
-
HEAL Initiative: Studies to Enable Analgesic Discovery (R61/R33 - Clinical Trial Not Allowed)
(RFA-NS-25-023)National Institute of Neurological Disorders and StrokeNational Institute on Alcohol Abuse and AlcoholismNational Institute on AgingNational Institute of Arthritis and Musculoskeletal and Skin DiseasesNational Cancer InstituteNational Institute of Dental and Craniofacial ResearchNational Institute of Diabetes and Digestive and Kidney DiseasesNational Eye InstituteEunice Kennedy Shriver National Institute of Child Health and Human DevelopmentNational Center for Complementary and Integrative HealthApplication Receipt Date(s): All applications are due by 5:00 PM local time of applicant organization. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
NIH Guide Notices are also available in an RSS feed (Really Simple Syndication).
Subscribe/Unsubscribe from the NIH Guide Weekly TOC LISTSERV.
For technical issues E-mail OER Webmaster